Burns Matteson Capital Management, LLC Viatris Inc Transaction History

Burns Matteson Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$8.77 - $10.85 $532,496 - $658,790	-60,718 Closed	0 $0
Q3 2023 Jan 12, 2024	BUY	$9.59 - $11.35 $582,285 - $689,149	60,718 New	60,718 $599 Million
Q2 2023 Dec 11, 2023	SELL	$9.02 - $10.29 $595,734 - $679,613	-66,046 Closed	0 $0
Q1 2023 Dec 11, 2023	SELL	$9.2 - $12.26 $13,100 - $17,458	-1,424 Reduced 2.11%	66,046 $635 Million
Q4 2022 Dec 11, 2023	BUY	$8.72 - $11.56 $588,338 - $779,953	67,470 New	67,470 $751 Million
Q3 2022 Dec 11, 2023	SELL	$8.48 - $11.13 $594,168 - $779,845	-70,067 Closed	0 $0
Q2 2022 Dec 11, 2023	BUY	$9.95 - $12.27 $697,166 - $859,722	70,067 New	70,067 $734 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.